@Sorepocket, I read and appreciated your post & points. I can understand in ‘normal’ times cost is an important consideration. I wonder though if it’s just not a case of time in hospital but also the effects of long Covid? The ongoing rehabilitation of people is going to be immense, unlike anything we have witnessed before on a world scale. There also seems to be cognitive & psychological symptoms that, to be honest, I don’t think society has experienced to such a high degree and been aware of at the time (would have occurred during war & post war times but as a society, we were not enlightened enough to probably acknowledge & deal with such illnesses).
If Remestemcel-L can stop such symptoms from happening, the immediate outlay, IMO, will be a most long term cost effective strategy.
MSB Trading 2021 - paradigm shift, page-110
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.015(1.40%) |
Mkt cap ! $1.238B | |||
| Open | High | Low | Value | Volume |
| $1.11 | $1.12 | $1.08 | $11.51M | 10.52M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 17804 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.09 | 230637 | 5 |
View Market Depth
| Last trade - 16.10pm 03/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.09 |
Change
0.015 ( 1.85 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 1937390 | ||
| Last updated 15.59pm 03/05/2024 ? | |||||
| MSB (ASX) Chart |